Engineered ICOSL Peptide Therapy Targets Integrin to Reduce Glomerular Kidney Damage
A synthetic peptide derived from inducible co-stimulator ligand selectively inhibits activated alpha-v-beta-3 integrin to protect podocytes and reduce proteinuria in ...










